Alka-Seltzer Plus Maximum Strength Sinus Congestion and Pain PowerFast Fizz 325 mg/1
chlorpheniramine maleate, dextromethorphan hydrobromide, acetaminophen, phenylephrine hydrochloride · TABLET, EFFERVESCENT · Bayer HealthCare LLC.
Alka-Seltzer Plus Maximum Strength Sinus Congestion and Pain PowerFast Fizz is a tablet, effervescent containing chlorpheniramine maleate, dextromethorphan hydrobromide, acetaminophen, phenylephrine hydrochloride at 325 mg/1, taken oral. Manufactured by Bayer HealthCare LLC..
Key Facts
- Brand Name
- Alka-Seltzer Plus Maximum Strength Sinus Congestion and Pain PowerFast Fizz
- Generic Name
- chlorpheniramine maleate, dextromethorphan hydrobromide, acetaminophen, phenylephrine hydrochloride
- NDC Code (Product)
0280-0055- Manufacturer
- Bayer HealthCare LLC.
- Strength
- 325 mg/1
- Dosage Form
- TABLET, EFFERVESCENT
- Route
- ORAL
- Marketing Status
- Application #
- M012
- Marketing Start
- 06/15/2021
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
Uses temporarily relieves these symptoms due to a cold or flu: minor aches and pains headache cough sore throat runny nose sneezing nasal congestion · sinus temporarily reduces fever
Dosage & Administration
Directions do not take more than the recommended dose adults and children 12 years and over: take 2 tablets fully dissolved in 4 oz of water every 4 hours. Do not exceed 10 tablets in 24 hours or as directed by a doctor. children under 12 years: do not use
Warnings
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take · more than 4,000 mg of acetaminophen in 24 hours · with other drugs containing acetaminophen · 3 or more alcoholic drinks every day while using this product Allergy alert: Acetaminophen may cause severe skin or severe allergic reactions. Symptoms may include: · skin reddening · blisters · rash · hives · facial swelling · asthma (wheezing) · shock If a skin or general allergic reaction occurs, stop use and seek medical help right away. Sore throat warning : If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly. Do not use to sedate children. Do not use with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask…
Frequently Asked Questions
What is Alka-Seltzer Plus Maximum Strength Sinus Congestion and Pain PowerFast Fizz used for?
Alka-Seltzer Plus Maximum Strength Sinus Congestion and Pain PowerFast Fizz contains chlorpheniramine maleate, dextromethorphan hydrobromide, acetaminophen, phenylephrine hydrochloride. It is a tablet, effervescent taken oral. Consult your doctor for specific uses.
Is Alka-Seltzer Plus Maximum Strength Sinus Congestion and Pain PowerFast Fizz a controlled substance?
Alka-Seltzer Plus Maximum Strength Sinus Congestion and Pain PowerFast Fizz is not classified as a controlled substance by the DEA.
What is the generic name for Alka-Seltzer Plus Maximum Strength Sinus Congestion and Pain PowerFast Fizz?
The generic name for Alka-Seltzer Plus Maximum Strength Sinus Congestion and Pain PowerFast Fizz is chlorpheniramine maleate, dextromethorphan hydrobromide, acetaminophen, phenylephrine hydrochloride. There are no other listed brand versions of chlorpheniramine maleate, dextromethorphan hydrobromide, acetaminophen, phenylephrine hydrochloride.
What is the NDC code for Alka-Seltzer Plus Maximum Strength Sinus Congestion and Pain PowerFast Fizz 325 mg/1?
The NDC (National Drug Code) for Alka-Seltzer Plus Maximum Strength Sinus Congestion and Pain PowerFast Fizz 325 mg/1 is 0280-0055, listed by Bayer HealthCare LLC..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)